The Texas Heart Institute in Houston leads innovations in cardiovascular health and cardiology, exemplified by its role in the first-in-human implantation of the BiVACOR Total Artificial Heart under the FDA Early Feasibility Study. Committed to advancing cardiovascular medicine, it integrates clinical expertise with education and cutting-edge medical technology, reaching a broad professional audience through its active engagement and authoritative presence in the field.

‌